Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Glenn E Wilcox is active.

Publication


Featured researches published by Glenn E Wilcox.


Separation Science and Technology | 2004

Isolation methods II: Column chromatography

Mark Guinn; Ronald Bates; Benjamin Hritzko; Teri Shanklin; Glenn E Wilcox; Sam Guhan

Summary This chapter briefly describes the various types of packing materials and equipment that can be utilized to isolate impurities from drug substances. It then goes into how to screen for impurity isolation and how to move from the screening phase of the project to develop an analytical-scale preparative method. The chapter concludes by giving rules on how to scale that preparative method up to any size column that will be used in the impurity isolation.


Archive | 2002

Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo[2,3]pyrimidine derivatives as protein kinases inhibitors

Glenn E Wilcox; Christian Koecher; Ton Vries; Mark Edwards Pfizer Global Rsearch Flanagan; Michael John Munchhof


Journal of Pharmaceutical Sciences | 2004

Pharmaceutical impurity identification: A case study using a multidisciplinary approach

Karen M. Alsante; Peter Boutros; Michel Couturier; Robert C. Friedmann; Jeffrey W. Harwood; George J. Horan; Andrew J. Jensen; Qicai Liu; Linda L. Lohr; Ronald Morris; Jeffrey W. Raggon; George L. Reid; Dinos Paul Santafianos; Thomas R. Sharp; John L. Tucker; Glenn E Wilcox


Organic Process Research & Development | 2003

Development of a Scaleable Route for the Production of cis-N-Benzyl-3-methylamino-4-methylpiperidine

David H. Brown Ripin; Stefan Abele; Weiling Cai; Todd Andrew Blumenkopf; Jeffrey M. Casavant; Jonathan L. Doty; Mark Edward Flanagan; Christian Koecher; Klaus Laue; Keith E. McCarthy; Cliff Meltz; Mike Munchhoff; Kees Pouwer; Bharat Shah; Jianmin Sun; John Teixeira; Ton Vries; David A. Whipple; Glenn E Wilcox


Archive | 2004

Chiral salt resolution

Glenn E Wilcox; Mark Edward Flanagan; Michael John Munchhof; Ton Vries; Christian Koecher


Archive | 1995

Pharmaceutical agents for the treatment of emesis

Harry A. Watson; William M Snyder; Glenn E Wilcox


Archive | 1994

Process for preparing and resolving 2-phenyl-3-aminopiperidine

William M Snyder; Harry A. Watson; Glenn E Wilcox


Organic Process Research & Development | 2012

Process Development of a Novel Azetidinyl Ketolide Antibiotic

Bryan Li; Thomas V. Magee; Richard A. Buzon; Daniel W. Widlicka; Dave R. Bill; Thomas A. Brandt; Xiaoping Cao; Michael Coutant; Haijian Dou; Karl Granskog; Mark Edward Flanagan; Cheryl Myers Hayward; Bin Li; Fengwei Liu; Wei Liu; Thuy-Trinh Nguyen; Jeffrey W. Raggon; Peter Robert Rose; Joseph Rainville; Usa Reilly; Yue Shen; Jianmin Sun; Glenn E Wilcox


Archive | 2008

RESOLUCIÓN DE SAL QUIRAL. (DIVISIONAL)

Glenn E Wilcox; Christian Koecher; Ton Vries; Mark Edward Flanagan; Michael John Munchhof


Archive | 2002

3-((3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidinyl)-3-oxo-propionitrile as protein kinase inhibitor

Glenn E Wilcox; Christian Koecher; Ton Vries; Mark Edwards Pfizer Global Rsearch Flanagan; Michael John Munchhof

Researchain Logo
Decentralizing Knowledge